ArticleGels (Basel, Switzerland)2026
Carbon Dot-Linked Hydrogel-Composite Scaffold with Sequential Release of Multi-Drug for Bone Repair.
Article in Gels (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bone repair is a complex and dynamic process that demands implanted scaffolds to provide temporal-specific functions: antibacterial activity in the early stage, followed by angiogenic and osteogenic stimulation in later stages. This study introduces a biomimetic scaffold composed of a filled Gel-OSA hydrogel and a 3D-printed PLA framework, enabling sequential multi-drug release for bone regeneration. Zero-dimensional arginine-derived carbon dots were incorporated into the hydrogel to achieve rapid release after implantation, conferring potent antibacterial activity and ROS regulation. Meanwhile, chondroitin sulfate (CS)-loaded mesoporous bioactive glass nanoparticles were immobilized onto the 3D-printed PLA surface via a polydopamine coating, allowing sustained release of CS and Ca/P ions to enhance the scaffold's long-term osteoinductive capability. The composite scaffold further demonstrated combined effects in promoting cell proliferation and osteogenic differentiation in vitro. Collectively, these findings suggest that this biomimetic scaffold, designed for temporally controlled multi-drug release, represents a promising therapeutic strategy for the reconstruction of bone tissue.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.